Displaying items by tag:

Tina Simpson, M.D., director of Faculty Development in the Department of Pediatrics, explains the training and other resources available from her office.

Investigators are contributing fresh approaches to homelessness, suicide and other issues facing veterans, while veteran students come to UAB in increasing numbers to prepare for new careers.

In keynote addresses at UAB’s COVID-19 Research Symposium, Anthony Fauci, M.D., and Kathleen Neuzil, M.D., shared the latest science on how COVID-19 spreads and the safety and efficacy of vaccines in late-stage trials.

With his idea for a coil that travels through the vasculature much like a sailboat riding the breeze, a UAB neuroradiologist has earned a commercialization grant from the U.S. Economic Development Administration.

Faculty, staff, student and community innovators were recognized for their 2020 contributions to COVID-19 research, innovation and entrepreneurship during the fifth annual UAB Innovation Awards presented by the Bill L. Harbert Institute for Innovation and Entrepreneurship Oct. 29.

Learn how UAB bioinformaticist Jake Chen, Ph.D., and computer scientist Da Yan, Ph.D., shifted their venerable gathering online and aided the fight against COVID-19.

Clinical trials of monoclonal antibodies and convalescent plasma offer new options to outpatients in the first days after a COVID-19 diagnosis.

With funding from UAB’s urgent COVID-19 research grants, researchers are testing penehyclidine to halt the acute respiratory distress syndrome seen in seriously ill patients by defending crucial cell barriers.

A novel detergent-like compound developed by UAB researchers that blocks HIV and HSV viruses from entering cells could have the same effect against the virus that causes COVID-19. The team is exploring the compound’s potential with a commercialization grant from the U.S. Economic Development Administration.

Colleagues explain say retiring Animal Resources Program Director Samuel Cartner, DVM, Ph.D., has helped shape the institution’s research.

Benjamin Larimer, Ph.D., has received a five-year, $1.5-million New Innovator Award grant to develop a PET imaging test that identifies patients most likely to benefit from immunotherapy.

Using extensive testing, diagnosis and clinical data from across the Deep South, this project will be the first to analyze multiple dimensions of inequality to clarify contributions to COVID-19 disparities.

ScopeAssist, invented by a physician and an engineer, is designed to help surgeons deal with the rigors associated with endoscopic surgeries.

Doctors don’t have anything to reliably collect urine from neonates. A solution to this problem earned a commercialization grant from the U.S. Economic Development Administration.

You, your co-workers and your family all benefit if you are participate in UAB’s randomized sentinel testing — and this simple, self-administered swab doesn’t take a test away from anyone else.

Can essential oils diffuse the coronavirus? What about keto diets? If UV rays kill viruses, should I wear sunblock? UAB’s Molly Fleece, M.D., is tackling common COVID-19 searches to counteract rampant misinformation online.

Most PPE goes on the provider, not the patient. A solution to this problem from UAB faculty earned them a commercialization grant from the U.S. Economic Development Administration.

An interdisciplinary team of faculty and graduate students are using machine learning to identify geographic areas in which social determinants contribute to the COVID-19 burden as a way to improve the public health response.

The immune system’s first responders are implicated in acute respiratory distress syndrome, which greatly increases mortality in patients with COVID-19. With pilot funding from UAB’s urgent COVID-19 research initiative, investigators are exploring a potentially powerful new form of treatment.

Ten graduate faculty were honored with the UAB Graduate Dean’s Excellence in Mentorship Award during a virtual reception Sept. 9. See what the award recipients say they learned from UAB’s up-and-coming scientists.

Moon Nahm, M.D., has identified the crucial antibodies for pneumococcal vaccines and helped lower prices from $100 per dose to $2. With pilot funding from UAB’s urgent COVID-19 research initiative, Nahm is adapting his proven techniques to SARS-CoV-2.

Alabamians have early access to potentially life-saving vaccines and treatments for COVID-19 through UAB. Why? The same reasons that clinical trials activity at UAB has more than doubled in the past five years. Here's how it happened.

A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.

UAB is enrolling patients as part of randomized controlled trials that experts say are necessary to prove the efficacy of the much-discussed COVID-19 treatment.

Twelve faculty have been selected to receive the President’s Award for Excellence in Teaching, which honors those who have demonstrated exceptional accomplishments in teaching. The 2020 honorees represent each school, the College of Arts and Sciences, the Honors College and the Graduate School.

Page 1 of 8